Development of a novel modified miR-15a mimic with enhanced therapeutic potential for treatment of pancreatic ductal adenocarcinoma

被引：0
|
作者：
Guo, Shixiang [1 ]
Fesler, Andrew [1 ]
Huang, Wenjie [2 ]
Wang, Yunchao [2 ]
Yang, Jiali [2 ]
Wang, Xianxing [2 ]
Hwang, Ga-Ram [1 ]
Godwin, Matthew [1 ]
Wang, Huaizhi [2 ]
Ju, Jingfang [1 ]
机构：
[1] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[2] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Inst Hepatopancreatobilialy Surg, Chongqing, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-2592
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2592
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma
    Guo, Shixiang
    Fesler, Andrew
    Huang, Wenjie
    Wang, Yunchao
    Yang, Jiali
    Wang, Xianxing
    Zheng, Yao
    Hwang, Ga-Ram
    Wang, Huaizhi
    Ju, Jingfang
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 19 : 228 - 239
  • [2] A novel miR-198-based mimic as a potential therapeutic against pancreatic ductal adenocarcinoma (PDAC).
    Marin-Muller, Christian
    Vega-Martinez, Osvaldo
    Chaves-Martinez, Laura
    Valverde-Hernandez, Juan C.
    Zamora-Rodriguez, Monica
    Lu, Jian-Ming
    Liu, Dongliang
    Chen, Changyi
    Yao, Qizhi Cathy
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Developing a novel miR-15a mimic as a potential therapeutic molecule to eliminate resistant colorectal cancer stem cells
    Fesler, Andrew T.
    Liu, Hua
    Wu, Ning
    Ju, Jingfang
    CANCER RESEARCH, 2017, 77
  • [4] Development of a novel miR-129 mimic with enhanced therapeutic potential for treatment of resistant colorectal cancer
    Fesler, Andrew T.
    Wu, Ning
    Liu, Hua
    Ju, Jingfang
    CANCER RESEARCH, 2017, 77
  • [5] TRAILshort is a Novel Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
    Khandakar, Binny
    Chandrasekar, Aswath P.
    Krogman, Ashton
    VanTreeck, Benjamin
    Cummins, Nathan
    Natesampillai, Sekar
    Garcia-Rivera, Enrique
    Rathore, Mahendra
    Khazaie, Khashayarsha
    Badley, Andrew
    Graham, Rondell
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1049 - 1049
  • [6] TRAILshort is a Novel Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
    Khandakar, Binny
    Chandrasekar, Aswath P.
    Krogman, Ashton
    VanTreeck, Benjamin
    Cummins, Nathan
    Natesampillai, Sekar
    Garcia-Rivera, Enrique
    Rathore, Mahendra
    Khazaie, Khashayarsha
    Badley, Andrew
    Graham, Rondell
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1049 - 1049
  • [7] miR-15a Inhibits Cell Proliferation of Pancreatic Ductal Adenocarcinoma (PDAC) by Downregulating BMI-1 Expression
    Guo, S. X.
    Wang, H. Z.
    PANCREAS, 2012, 41 (08) : 1362 - 1362
  • [8] Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
    Kuznetsova, Alla
    Popova, Olga
    Panchenkov, Dmitry
    Dyuzheva, Tatyana
    Ivanov, Alexey
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (03) : 619 - 643
  • [9] Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
    Alla Kuznetsova
    Olga Popova
    Dmitry Panchenkov
    Tatyana Dyuzheva
    Alexey Ivanov
    Clinical and Experimental Medicine, 2023, 23 : 619 - 643
  • [10] EZH2 AS A NOVEL THERAPEUTIC TARGET FOR TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA
    Avan, A.
    Paolicchi, E.
    Crea, F.
    Funel, N.
    Galvani, E.
    Marquez, V.
    Honeywell, R.
    Danesi, R.
    Peters, G. J.
    Giovannetti, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 31 - 32
12345